Want to join the conversation?
$URBN said total SG&A expenses for 2Q17 were up 5% to $224MM. Total SG&A as a percentage of sales deleveraged by 48 Bps to 25.2%. This deleverage was mainly due to an increase in direct marketing and technology-related expenses to support the company's strong direct-to-consumer growth.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?